Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Goodwin

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Cancers|December 10, 2021
GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic ModelsAnke Brüning-Richardson, Gary C Shaw, Daniel Tams, et al.
Nature Communications|December 12, 2022
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancerSally J Adua, Anna Arnal-Estapé, Minghui Zhao, et al.
Cancers|August 12, 2022
Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. <i>Cancers</i> 2021, <i>13</i>, 5939Anke Brüning-Richardson, Gary C Shaw, Daniel Tams, et al.
Journal of the American Society for Mass Spectrometry|November 12, 2021
Holistic Characterization of a <i>Salmonella</i> Typhimurium Infection Model Using Integrated Molecular ImagingNicole Strittmatter, Panchali Kanvatirth, Paolo Inglese, et al.
NPJ Breast Cancer|August 18, 2023
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical modelsLorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson, et al.
Nature Communications|July 16, 2024
Metabolic imaging across scales reveals distinct prostate cancer phenotypesNikita Sushentsev, Gregory Hamm, Lucy Flint, et al.
NPJ Breast Cancer|September 19, 2023
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical modelsLorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson, et al.
NPJ Breast Cancer|August 5, 2023
Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical modelsLorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson, et al.
Analytical Chemistry|September 11, 2025
A New Approach to Large Multiomics Data IntegrationAlex Dexter, Spencer A Thomas, Rory T Steven, et al.
Nature Immunology|August 5, 2020
ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lungMartijn J Schuijs, Shaun Png, Arianne C Richard, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Cancers|December 10, 2021
GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic ModelsAnke Brüning-Richardson, Gary C Shaw, Daniel Tams, et al.
Nature Communications|December 12, 2022
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancerSally J Adua, Anna Arnal-Estapé, Minghui Zhao, et al.
Cancers|August 12, 2022
Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. <i>Cancers</i> 2021, <i>13</i>, 5939Anke Brüning-Richardson, Gary C Shaw, Daniel Tams, et al.
Journal of the American Society for Mass Spectrometry|November 12, 2021
Holistic Characterization of a <i>Salmonella</i> Typhimurium Infection Model Using Integrated Molecular ImagingNicole Strittmatter, Panchali Kanvatirth, Paolo Inglese, et al.
NPJ Breast Cancer|August 18, 2023
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical modelsLorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson, et al.
Nature Communications|July 16, 2024
Metabolic imaging across scales reveals distinct prostate cancer phenotypesNikita Sushentsev, Gregory Hamm, Lucy Flint, et al.
NPJ Breast Cancer|September 19, 2023
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical modelsLorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson, et al.
NPJ Breast Cancer|August 5, 2023
Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical modelsLorna Hopcroft, Eleanor M Wigmore, Stuart C Williamson, et al.
Analytical Chemistry|September 11, 2025
A New Approach to Large Multiomics Data IntegrationAlex Dexter, Spencer A Thomas, Rory T Steven, et al.
Nature Immunology|August 5, 2020
ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lungMartijn J Schuijs, Shaun Png, Arianne C Richard, et al.
Pageof 13